| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 111.84× | 111.84× | 117.44× | 107.28× | 109.35× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 2.26× | 2.27× | 1.97× | 1.86× | 1.56× | ||
| 0.47× | 0.47× | 0.44× | 0.46× | 0.40× | ||
| −11.58× | −11.58× | 2.14× | 3.80× | −8.80× | ||
| 1.90× | 1.90× | 0.33× | 1.18× | 1.31× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 109.35 | 107.28 | 117.44 | 111.84 | 111.84 | |
| Working Capital Turnover | 1.56 | 1.86 | 1.97 | 2.27 | 2.26 | |
| Asset Turnover | 0.40 | 0.46 | 0.44 | 0.47 | 0.47 | |
| Cash Conversion (CFO/Net Income) | -8.80 | 3.80 | 2.14 | -11.58 | -11.58 | |
| CFO/EBITDA | 1.31 | 1.18 | 0.33 | 1.90 | 1.90 |